ATE359765T1 - Verringerung der teilchengrösse von bioaktiven verbindungen - Google Patents
Verringerung der teilchengrösse von bioaktiven verbindungenInfo
- Publication number
- ATE359765T1 ATE359765T1 AT04761482T AT04761482T ATE359765T1 AT E359765 T1 ATE359765 T1 AT E359765T1 AT 04761482 T AT04761482 T AT 04761482T AT 04761482 T AT04761482 T AT 04761482T AT E359765 T1 ATE359765 T1 AT E359765T1
- Authority
- AT
- Austria
- Prior art keywords
- reducing
- particle size
- active compound
- biologically active
- bioactive compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000002245 particle Substances 0.000 title abstract 4
- 230000000975 bioactive effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 239000012530 fluid Substances 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0319797.7A GB0319797D0 (en) | 2003-08-26 | 2003-08-26 | Particle size reduction of poorly soluble drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE359765T1 true ATE359765T1 (de) | 2007-05-15 |
Family
ID=28460161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04761482T ATE359765T1 (de) | 2003-08-26 | 2004-08-25 | Verringerung der teilchengrösse von bioaktiven verbindungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7666307B2 (de) |
| EP (1) | EP1658052B1 (de) |
| JP (1) | JP2007503399A (de) |
| AT (1) | ATE359765T1 (de) |
| DE (1) | DE602004006000T2 (de) |
| ES (1) | ES2286655T3 (de) |
| GB (1) | GB0319797D0 (de) |
| WO (1) | WO2005018611A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005089718A2 (en) * | 2004-03-23 | 2005-09-29 | Novartis Ag | Pharmaceutical compositions |
| CA2597716A1 (en) * | 2005-02-15 | 2006-08-24 | Elan Pharma International Limited | Aerosol and injectable formulations of nanoparticulate benzodiazepine |
| CN1948190B (zh) * | 2006-11-07 | 2012-07-25 | 南京大学 | 氟洛芬生产废水的处理方法 |
| GB0705159D0 (en) | 2007-03-19 | 2007-04-25 | Prosonix Ltd | Process for making crystals |
| WO2009026461A2 (en) | 2007-08-21 | 2009-02-26 | Board Of Regents, The University Of Texas System | Thermo-kinetic mixing for pharmaceutical applications |
| WO2009026647A1 (en) * | 2007-08-30 | 2009-03-05 | The University Of Queensland | Method and apparatus for breaking solid materials |
| GB0818403D0 (en) * | 2008-10-08 | 2008-11-12 | Univ Leuven Kath | Aqueous electrophoretic deposition |
| EP2334845A2 (de) * | 2008-10-06 | 2011-06-22 | Katholieke Universiteit Leuven K.U. Leuven R&D | Funktionelle schichten von biomolekülen und lebenden zellen und neues system zu ihrer herstellung |
| CN103957891B (zh) * | 2011-09-23 | 2017-01-11 | 美利坚合众国由健康及人类服务部部长代表 | 基于流感血凝素蛋白的新颖疫苗 |
| WO2013056232A2 (en) * | 2011-10-13 | 2013-04-18 | Case Western Reserve University | Rxr agonists compounds and methods |
| EP3906939A1 (de) | 2013-10-11 | 2021-11-10 | The United States of America, represented by the Secretary, Department of Health and Human Services | Epstein-barr-virus-impfstoffe |
| BR112017014219A2 (pt) | 2014-12-31 | 2018-03-06 | The Usa As Represented By The Secretary Dept Of Health And Human Services | vacinas à base de nanopartículas multivalentes |
| CA3035443A1 (en) | 2016-09-02 | 2018-03-08 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof |
| US10824822B2 (en) * | 2019-02-05 | 2020-11-03 | International Business Machines Corporation | Magnetic tracking for medicine management |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3133023A (en) | 1961-06-26 | 1964-05-12 | Ibm | Preparation of coatings and printing inks |
| BE647891A (de) | 1962-08-03 | |||
| DE2023526A1 (de) | 1970-05-14 | 1971-11-25 | Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt | Verfahren zur Herstellung von schrumpfarmen Polyesterfäden |
| DE2121769C3 (de) | 1970-05-18 | 1978-08-17 | Vostotschnyj Nautschno-Issledovatelskij Gornorudnyj Institut, Nowokusnezk (Sowjetunion) | Verfahren und Vorrichtung zur Zerkleinerung von vorzugsweise elektrisch leitendem Material |
| JPS50116378A (de) | 1973-04-27 | 1975-09-11 | ||
| SU627334A1 (ru) * | 1977-05-26 | 1978-10-05 | Всесоюзный Научно-Исследовательский Институт Продуктов Брожения | Способ измельчени и дозировочного отпуска материала |
| GB2065157B (en) | 1979-12-17 | 1983-08-24 | Troyfel Products Ltd | Method of producing cement colouring composition |
| DE3407608A1 (de) | 1983-03-01 | 1984-09-06 | Misaki Shipbuilding & Engineering Co., Ltd., Tokio/Tokyo | Vorrichtung zur pulverisierung, insbesondere kugelmuehle, und zur klassifizierung von teilchengroessen |
| DE3802521A1 (de) * | 1988-01-28 | 1989-08-10 | Mueller Bernhard | Verfahren zur behandlung von substanzen mit einem magnetfeld |
| JPH03254886A (ja) * | 1990-03-02 | 1991-11-13 | Toto Ltd | 溶液中の微粒子の凝集または壁面への付着防止方法 |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| DE4228229C1 (de) * | 1992-08-25 | 1993-12-09 | Dieter Jossner | Verfahren und Vorrichtung zur Erzeugung von Nebeln |
| DE69612390T2 (de) | 1995-08-28 | 2001-10-31 | Advanced Nano Technologies Pty. Ltd., Nedlands | Verfahren zur herstellung ultrafeiner teilchen |
| RO120603B1 (ro) | 1996-08-22 | 2006-05-30 | Research Triangle Pharmaceuticals Ltd. | Compoziţie conţinând microparticule de substanţe insolubile în apă şi procedeu de preparare |
| US6045829A (en) | 1997-02-13 | 2000-04-04 | Elan Pharma International Limited | Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
| KR19990001564A (ko) | 1997-06-16 | 1999-01-15 | 유충식 | 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제 |
| JPH11151437A (ja) | 1997-07-29 | 1999-06-08 | Ska Kk | 微粒子の製造方法と装置 |
| FR2776945B1 (fr) | 1998-04-06 | 2000-06-16 | Cs Systemes De Securite 3Cs | Procede de desagregation ou de desagglomeration d'amas particulaires, procede de preparation d'un beton ou d'un mortier et beton ou mortier ainsi obtenu |
| US6271130B1 (en) | 1998-11-25 | 2001-08-07 | The University Of Chicago | Semiconductor assisted metal deposition for nanolithography applications |
| ATE307808T1 (de) | 1999-03-24 | 2005-11-15 | Scherer Technologies Inc R P | Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser |
| JP2001348581A (ja) | 2000-06-08 | 2001-12-18 | Shigemi Sawada | 液体分子クラスタ微細化装置及び方法 |
| JP4529242B2 (ja) | 2000-06-22 | 2010-08-25 | 栗田工業株式会社 | 水処理方法 |
| JP4854842B2 (ja) * | 2000-10-20 | 2012-01-18 | 独立行政法人科学技術振興機構 | 粒子の制御方法 |
| AT410171B (de) * | 2001-05-10 | 2003-02-25 | Zwittnig Leopold | Getränk |
| GB0204430D0 (en) * | 2002-02-26 | 2002-04-10 | Leuven K U Res & Dev | Magnet |
| PT1560641E (pt) * | 2002-11-14 | 2006-07-31 | Leuven K U Res & Dev | Metodo para a preparacao de emulsoes |
| JP2006285363A (ja) | 2005-03-31 | 2006-10-19 | Konica Minolta Photo Imaging Inc | Ｉｃカード |
-
2003
- 2003-08-26 GB GBGB0319797.7A patent/GB0319797D0/en not_active Ceased
-
2004
- 2004-08-25 DE DE602004006000T patent/DE602004006000T2/de not_active Expired - Lifetime
- 2004-08-25 JP JP2006524181A patent/JP2007503399A/ja active Pending
- 2004-08-25 US US10/595,119 patent/US7666307B2/en not_active Expired - Fee Related
- 2004-08-25 AT AT04761482T patent/ATE359765T1/de active
- 2004-08-25 ES ES04761482T patent/ES2286655T3/es not_active Expired - Lifetime
- 2004-08-25 EP EP04761482A patent/EP1658052B1/de not_active Expired - Lifetime
- 2004-08-25 WO PCT/BE2004/000121 patent/WO2005018611A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1658052A1 (de) | 2006-05-24 |
| US7666307B2 (en) | 2010-02-23 |
| ES2286655T3 (es) | 2007-12-01 |
| GB0319797D0 (en) | 2003-09-24 |
| EP1658052B1 (de) | 2007-04-18 |
| US20070082054A1 (en) | 2007-04-12 |
| DE602004006000D1 (de) | 2007-05-31 |
| WO2005018611A1 (en) | 2005-03-03 |
| DE602004006000T2 (de) | 2008-01-17 |
| JP2007503399A (ja) | 2007-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE359765T1 (de) | Verringerung der teilchengrösse von bioaktiven verbindungen | |
| ATE437207T1 (de) | Verfahren zur reduzierung der teilchengrösse von metallverbindungen | |
| DE60325718D1 (de) | Nystatin-nanopartikelzusammensetzungen | |
| ATE415946T1 (de) | Neue metaxalon-zusammensetzungen | |
| ATE387186T1 (de) | Neue zusammensetzungen von sildenafil-freier base | |
| DE50205890D1 (de) | Nanopartikuläre zubereitung | |
| ATE427983T1 (de) | Bariumsulfat, verfahren zu dessen herstellung und dessen verwendung | |
| ATE431131T1 (de) | Meloxican-formulierungen in nanoteilchenform | |
| DE60326383D1 (de) | Zusammensetzungen von magnetischen partikeln mit gem-biphosphonate derivaten beschichtet | |
| DK1446367T3 (da) | Fremgangsmåde til hærdning af en flydende masse | |
| ATE343376T1 (de) | Nanopartikelzusammensetzungen von angiogeneseinhibitoren | |
| UA93351C2 (uk) | Похідні фталазіну як інгібітори parp | |
| CY1113036T1 (el) | Φαρμακοτεχνικες μορφες νανοσωματιδιων μεγεστρολης | |
| ATE377973T1 (de) | Fluidsystem mit internem filter | |
| ATE385777T1 (de) | Nanopartikelzusammensetzungen von mitogen- aktivierten protein (map) kinase inhibitoren | |
| AR061087A1 (es) | Suspension de hidrogel y su proceso de fabricacion | |
| DE602004032232D1 (de) | Arzneistoffzufuhrvorrichtung, die einen wirkstoff enthält, und verfahren zur freisetzung eines wirkstoffs aus einer arzneistoffzufuhrvorrichtung | |
| BRPI0412699A (pt) | compostos e particulados hidrofóbicos e aplicações destes | |
| DE60212984D1 (de) | Shampoo mit hohlen teilchen | |
| ATE455161T1 (de) | Granulate aus pulverförmigem mineralstoff und verfahren zur herstellung der granulate | |
| IL171875A0 (en) | Pioglitazone salts,such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same | |
| BRPI0014880B8 (pt) | composição farmacêutica aquosa contendo ciclosonida | |
| WO2003106060A3 (fr) | Dispositif de nettoyage d'une surface d'une piece | |
| ATE275100T1 (de) | Sequestrierung | |
| SG162811A1 (en) | Nanoparticulate and controlled release compositions comprising aryl- heterocyclic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1658052 Country of ref document: EP |